A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma.

Xiao WuWenfeng YuR H PetersenHongxu ShengYiqing WangWang LvJian Hu

Published in: BMC cancer (2020)

The competing risk nomogram displayed excellent discrimination and calibration for predicting LC-SM. With the aid of this individualized predictive tool, clinicians can more expediently devise appropriate treatment protocols and follow-up schedules.

Keyphrases

lymph node metastasis
palliative care
cardiovascular events
squamous cell carcinoma
risk factors
simultaneous determination
replacement therapy
low cost